News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
342,427 Results
Type
Article (27440)
Company Profile (146)
Press Release (314841)
Multimedia
Podcasts (30)
Webinars (11)
Section
Business (96424)
Career Advice (1312)
Deals (15679)
Drug Delivery (80)
Drug Development (39993)
Employer Resources (155)
FDA (8360)
Job Trends (8847)
News (162636)
Policy (14484)
Tag
Academia (1977)
Academic (2)
Accelerated approval (3)
Adcomms (17)
Allergies (76)
Alliances (26536)
ALS (70)
Alzheimer's disease (863)
Antibody-drug conjugate (ADC) (75)
Approvals (8395)
Artificial intelligence (179)
Autoimmune disease (13)
Automation (12)
Bankruptcy (109)
Best Places to Work (7411)
BIOSECURE Act (13)
Biosimilars (67)
Biotechnology (90)
Bladder cancer (56)
Brain cancer (17)
Breast cancer (169)
Cancer (1246)
Cardiovascular disease (109)
Career advice (1157)
Career pathing (33)
CAR-T (91)
Cell therapy (268)
Cervical cancer (13)
Clinical research (32767)
Collaboration (552)
Compensation (226)
Complete response letters (12)
COVID-19 (1335)
CRISPR (31)
C-suite (182)
Cystic fibrosis (82)
Data (1470)
Decentralized trials (1)
Denatured (21)
Depression (30)
Diabetes (168)
Diagnostics (3431)
Digital health (8)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (72)
Drug pricing (61)
Drug shortages (5)
Duchenne muscular dystrophy (64)
Earnings (29067)
Editorial (18)
Employer branding (24)
Employer resources (134)
Events (51166)
Executive appointments (547)
FDA (9252)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (514)
Gene editing (73)
Generative AI (16)
Gene therapy (217)
GLP-1 (400)
Government (2314)
Grass and pollen (2)
Guidances (82)
Healthcare (10102)
Huntington's disease (16)
IgA nephropathy (20)
Immunology and inflammation (49)
Indications (16)
Infectious disease (1423)
Inflammatory bowel disease (107)
Inflation Reduction Act (8)
Influenza (27)
Intellectual property (53)
Interviews (196)
IPO (6783)
IRA (23)
Job creations (1777)
Job search strategy (1009)
Kidney cancer (2)
Labor market (39)
Layoffs (194)
Leadership (16)
Legal (2608)
Liver cancer (44)
Lung cancer (170)
Lymphoma (94)
Machine learning (4)
Management (52)
Manufacturing (186)
MASH (31)
Medical device (6397)
Medtech (6401)
Mergers & acquisitions (9268)
Metabolic disorders (388)
Multiple sclerosis (52)
NASH (11)
Neurodegenerative disease (46)
Neuropsychiatric disorders (8)
Neuroscience (1229)
NextGen: Class of 2025 (3697)
Non-profit (3459)
Now hiring (39)
Obesity (192)
Opinion (131)
Ovarian cancer (49)
Pain (58)
Pancreatic cancer (44)
Parkinson's disease (103)
Partnered (14)
Patents (112)
Patient recruitment (67)
Peanut (42)
People (35021)
Pharmaceutical (41)
Pharmacy benefit managers (4)
Phase I (9382)
Phase II (14058)
Phase III (12136)
Pipeline (748)
Policy (70)
Postmarket research (1409)
Preclinical (4076)
Press Release (61)
Prostate cancer (61)
Psychedelics (18)
Radiopharmaceuticals (126)
Rare diseases (281)
Real estate (3293)
Recruiting (59)
Regulatory (10764)
Reports (44)
Research institute (1740)
Resumes & cover letters (165)
Rett syndrome (5)
RNA editing (2)
RSV (32)
Schizophrenia (49)
Series A (94)
Series B (57)
Service/supplier (8)
Sickle cell disease (40)
Special edition (8)
Spinal muscular atrophy (109)
Sponsored (24)
Startups (2413)
State (1)
Stomach cancer (8)
Supply chain (29)
Tariffs (11)
The Weekly (9)
Vaccines (326)
Venture capitalists (32)
Weight loss (117)
Women's health (16)
Worklife (18)
Date
Last 7 days (527)
Last 30 days (1703)
Last 365 days (18879)
2025 (6884)
2024 (20467)
2023 (23022)
2022 (29265)
2021 (32079)
2020 (29557)
2019 (25914)
2018 (19347)
2017 (17190)
2016 (16712)
2015 (18790)
2014 (13768)
2013 (11003)
2012 (11447)
2011 (11774)
2010 (10702)
Location
Africa (488)
Alabama (30)
Alaska (7)
Arizona (101)
Arkansas (10)
Asia (19154)
Australia (3435)
California (3558)
Canada (1042)
China (248)
Colorado (137)
Connecticut (175)
Delaware (119)
Europe (56336)
Florida (562)
Georgia (138)
Hawaii (1)
Idaho (23)
Illinois (286)
India (22)
Indiana (262)
Iowa (9)
Japan (139)
Kansas (47)
Kentucky (15)
Louisiana (8)
Maine (14)
Maryland (477)
Massachusetts (2780)
Michigan (130)
Minnesota (209)
Mississippi (2)
Missouri (46)
Montana (17)
Nebraska (11)
Nevada (43)
New Hampshire (18)
New Jersey (1131)
New Mexico (19)
New York (1067)
North Carolina (669)
North Dakota (8)
Northern California (1596)
Ohio (132)
Oklahoma (7)
Oregon (22)
Pennsylvania (774)
Puerto Rico (9)
Rhode Island (16)
South America (645)
South Carolina (10)
Southern California (1296)
Tennessee (43)
Texas (448)
United States (13587)
Utah (87)
Virginia (80)
Washington D.C. (43)
Washington State (239)
West Virginia (1)
Wisconsin (49)
342,427 Results for "tiziana life sciences plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis
May 7, 2025
·
7 min read
Press Releases
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer’s Patient Treated with Intranasal Foralumab
May 9, 2025
·
7 min read
Press Releases
Tiziana Life Sciences to Present at the 37th Annual Roth Conference
March 18, 2025
·
3 min read
Press Releases
Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial
April 24, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
February 26, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
February 24, 2025
·
6 min read
Press Releases
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial
April 2, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program
February 19, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
March 5, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
February 12, 2025
·
6 min read
1 of 34,243
Next
